Fidia Farmaceutici enters Italian pediatric market segment

3 July 2015

Privately-held Italian drugmaker Fidia Farmaceutici plans to enter the Italian pediatric health care market with the acquisition of the HalyKoo Line developed by the Swiss-based company APR Applied Pharma Research specialized in the development of innovative and patent-protected products (prescription and over-the-counter), that are marketed worldwide

The HalyKoo products will be available in Italy starting next fall: this isthe first complete line of products offering, under only one unique brand, tailor-made therapeutic solutions, designed and developed for children’s health and wellbeing since newborns.

This partnership has enabled Fidia, which is specialized in the R&D and marketing of innovative products based on hyaluronic acid, to officially enter the pediatric market segment.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical